, the authors concluded that endovascular
revascularization should be the Ô¨Årst line of therapy for
patients with CMI. Lima et al117 performed a similar analysis using the same database from the years 2007 to 2014
to examine the impact of the choice of revascularization
on major cardiac and cerebrovascular events. In their
propensity-matched cohort, they reported that the major cardiac and cerebrovascular events and composite